Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hodgkin's Lymphoma (HL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03033914
What this trial is testing

A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)

Who this might be right for
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 82
Testing effectiveness (Phase 2)Looking for participantsNCT03125642
What this trial is testing

Auto Stem Cell Transplant for Lymphoma Patients

Who this might be right for
Non-Hodgkin LymphomaHodgkin Lymphoma
Masonic Cancer Center, University of Minnesota 150
Not applicableStudy completedNCT01248000
What this trial is testing

The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy

Who this might be right for
Histologically Confirmed Classical Hodgkin Lymphoma According to the Current World Health Organisation Classification
Gruppo Italiano Studio Linfomi 136
Testing effectiveness (Phase 2)Study completedNCT01716806
What this trial is testing

Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Hodgkin DiseasePeripheral T Cell Lymphoma
Seagen Inc. 131
Not applicableStudy completedNCT07120217
What this trial is testing

Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment.

Who this might be right for
Hodgkin DiseaseBreast CancerLiposomal Doxorubicin
Federico II University 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT05502250
What this trial is testing

Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission

Who this might be right for
Hodgkin Lymphoma
Stichting Hemato-Oncologie voor Volwassenen Nederland 75
Testing effectiveness (Phase 2)Study completedNCT02227433
What this trial is testing

Brentuximab Vedotin in the Elderly Hodgkin Lymphoma Patients at First Relapse or With Primary Refractory Disease.

Who this might be right for
Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 20
Testing effectiveness (Phase 2)Study completedNCT03615664
What this trial is testing

The Efficacy of Salvage BGD With autoSCT Consolidation in Advanced Classical HL Patients Not Responding to ABVD

Who this might be right for
Hodgkin's Lymphoma
Polish Lymphoma Research Group 115
Not applicableUnknownNCT04776265
What this trial is testing

RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT

Who this might be right for
Hodgkin Lymphoma, AdultRelapsed Hodgkin's Disease, AdultRefractory Hodgkin Lymphoma
Grupo Argentino de Tratamiento de la Leucemia Aguda 100
Testing effectiveness (Phase 2)Study completedNCT02939014
What this trial is testing

Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)

Who this might be right for
Hodgkin DiseaseLymphoma, Large-Cell, Anaplastic
Takeda 39
Early research (Phase 1)Study completedNCT01705847
What this trial is testing

A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies

Who this might be right for
Lymphoid Malignancies
Gilead Sciences 39
Not applicableEnded earlyNCT00879528
What this trial is testing

Consolidation PET-based and Donor-based After Salvage Therapy in Patients With HL in Relapse or Refractory

Who this might be right for
Hodgkin's Lymphoma
Fondazione Italiana Linfomi - ETS 264
Not applicableStudy completedNCT07145125
What this trial is testing

Real-life Efficacy and Toxicity of Brentuximab-Vedotin Associated With Bendamustine in Patients With Relapsed or Refractory Hodgkin Lymphoma (HL-R2-B2)

Who this might be right for
Relapsed or Refractory Hodgkin Lymphoma
University Hospital, Bordeaux 222
Large-scale testing (Phase 3)Study completedNCT01034163
What this trial is testing

A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL)

Who this might be right for
Hodgkin's Lymphoma
Novartis Pharmaceuticals 41
Not applicableStudy completedNCT03766516
What this trial is testing

Registry of BrentuximabVedotinin Patients With R/R Anaplastic Large Cell Lymphoma or Classical HL

Who this might be right for
Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin Lymphoma
Samsung Medical Center 90
Testing effectiveness (Phase 2)Looking for participantsNCT06090864
What this trial is testing

ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

Who this might be right for
Hodgkin LymphomaRelapseRefractory
UNC Lineberger Comprehensive Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT01453504
What this trial is testing

Everolimus in Combination With DHAP in Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Cologne 73
Testing effectiveness (Phase 2)Study completedNCT00670592
What this trial is testing

Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's Lymphoma
Novartis Pharmaceuticals 111
Not applicableLooking for participantsNCT03869619
What this trial is testing

REal World Data in LYmphoma and Survival in Adults

Who this might be right for
Diffuse Large B Lymphoma (DLBCL)Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)+4 more
Hospices Civils de Lyon 6,000
Testing effectiveness (Phase 2)Study completedNCT00848926
What this trial is testing

A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma

Who this might be right for
Disease, Hodgkin
Seagen Inc. 102
Next Page